![](/img/cover-not-exists.png)
Higher discontinuation and lower survival rates are likely in elderly Japanese patients with advanced hepatocellular carcinoma receiving sorafenib
Manabu Morimoto, Kazushi Numata, Masaaki Kondo, Hisashi Hidaka, Juichi Takada, Akitaka Shibuya, Satoshi Kobayashi, Shinichi Ohkawa, Chiaki Okuse, Satoshi Morita, Masataka Taguri, Katsuaki TanakaVolume:
41
Year:
2011
Language:
english
DOI:
10.1111/j.1872-034x.2011.00778.x
File:
PDF, 201 KB
english, 2011